Gilead Sciences Inc (GILD)
107.87
+1.13
(+1.06%)
USD |
NASDAQ |
Mar 25, 16:00
108.00
+0.13
(+0.12%)
After-Hours: 20:00
Gilead Sciences Price to Book Value: 6.950 for March 25, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Amgen Inc | 28.05 |
| Johnson & Johnson | 5.428 |
| Eli Lilly and Co | 53.96 |
| Vertex Pharmaceuticals Inc | 7.966 |
| Moderna Inc | 1.201 |
Price to Book Value Related Metrics
| PE Ratio | 291.54 |
| PS Ratio | 4.719 |
| Price to Free Cash Flow | 13.17 |
| Price | 107.87 |
| Earnings Yield | 0.34% |
| Market Cap | 134.34B |
| Operating PE Ratio | 16.81 |
| Normalized PE Ratio | 22.44 |